Munich - Delayed Quote EUR
Green Thumb Industries Inc (R9U2.MU)
5.07
0.00
(0.00%)
At close: May 16 at 8:00:12 AM GMT+2
Loading Chart for R9U2.MU
- Previous Close
5.07 - Open
5.07 - Bid --
- Ask --
- Day's Range
5.07 - 5.07 - 52 Week Range
4.50 - 12.24 - Volume
0 - Avg. Volume
58 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.MU
View MorePerformance Overview: R9U2.MU
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
R9U2.MU
31.14%
S&P/TSX Composite index (^GSPTSE)
5.49%
1-Year Return
R9U2.MU
59.51%
S&P/TSX Composite index (^GSPTSE)
16.47%
3-Year Return
R9U2.MU
59.09%
S&P/TSX Composite index (^GSPTSE)
28.53%
5-Year Return
R9U2.MU
32.91%
S&P/TSX Composite index (^GSPTSE)
77.42%
Compare To: R9U2.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.07
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.5750
+5.29%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.0960
+5.19%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2360
0.00%
Mkt Cap EUR 79.093M
Industry Drug Manufacturers—Specialty & Generic
0.5850
-4.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.4100
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1840
+8.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6000
-4.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0700
0.00%
Mkt Cap EUR 14.206M
Industry Drug Manufacturers—Specialty & Generic
0.0070
0.00%
Mkt Cap EUR 2.51M
Industry Drug Manufacturers—Specialty & Generic
4.4950
+3.45%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.MU
View MoreValuation Measures
As of 5/15/2025
Market Cap
1.20B
Enterprise Value
1.49B
Trailing P/E
26.97
Forward P/E
24.75
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.20
Price/Book (mrq)
0.74
Enterprise Value/Revenue
1.46
Enterprise Value/EBITDA
4.52
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--